Blog Archives

Scleral lenses for Sjogren’s Syndrome

Most contact lens wearers who develop Sjogren’s Syndrome find that they need to bid farewell to their contacts due to eye dryness. Many of these patients don’t realize that there is a contact option that not only allows them to

Posted in Treatment Tagged with: , , ,

Another dry eye treatment, Elate by Cambium, cleared for phase 1/2 trials

It has been nearly 15 years since Restasis was approved to treat dry eyes. SS patients had to make due with Restasis until last year when Xiidra was approved. The floodgates seemed to have opened, as a variety of dry eye

Posted in Clinical Trials, Research, Treatment Tagged with: , ,

Lamelleye and Lacripep enter clinical trials, adding more eye drop options for Sjogren’s Syndrome patients

Sjogren’s Syndrome patients are experiencing a growing number of options for treating dry eyes. Restasis (Ciclosporin) was the first, and a treatment with which I’ve found some success. Xiidra (Lifitegrast) was approved just last year, and while it is an eye

Posted in Clinical Trials, Treatment Tagged with:

Xiidra (Lifitegrast), a new prescription eye drop for dry eye, approved by the FDA

For the first time in over 10 years (since Restasis), a treatment for dry eye has been approved by the FDA. The approval happened in July: According to the company, in all four studies, a larger reduction in eye dryness

Posted in Patient Care, Treatment Tagged with: ,
WordPress Appliance - Powered by TurnKey Linux